The U.S. Food and Drug Administration issued a warning to doctors who are prescribing amiodarone for their atrial fibrillation patients saying that those patients should take no more than 20 milligrams of Zocor®, Simcor®, or Vytorin®.

Read about FDA warning …

Tags: Statins, Treatment //

Related Posts

• If Catheter Ablation Reduces Alzheimer’s Disease and Stroke Risk Then Keeping Atrial Fibrillation Patients in Sinus Rhythm May Become the Goal
• Dr. Peter Kowey Discusses New Atrial Fibrillation Treatments – Video
• New AFib Educator iPhone App and Desktop Widget Helps Atrial Fibrillation Patients and Doctors Communicate
• Urgent Request for UK Atrial Fibrillation Patients to Contact NICE About Dronedarone
• Action for Stroke Prevention Launches How Can We Avoid a Stroke Crisis? To Expose Risk of a Stroke Crisis in Europe from Atrial Fibrillation
• October 29, 2009 is World Stroke Day: What Atrial Fibrillation Patients Should Know About Stroke Risk
• Can Atrial Fibrillation Patients Decrease Swine Flu Death Risk with a Pneumonia Shot
• Atrial Fibrillation Patients Needed for Clinical Trial
• StopAfib.org applauds FDA approval of Multaq® (dronedarone), a safer option to amiodarone for atrial fibrillation (afib) patients
• StopAfib.org Speaks on Behalf of Atrial Fibrillation Patients at FDA Hearing on Amiodarone Replacement
• Amiodarone Replacement Gets the Fast Track